Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
针对刺突蛋白上两个免疫优势表位的单克隆抗体可中和新出现的、令人担忧的SARS-CoV-2变异株。
期刊:EBioMedicine
影响因子:9.7
doi:10.1016/j.ebiom.2022.103818
Branislav Kovacech ,Lubica Fialova ,Peter Filipcik ,Rostislav Skrabana ,Monika Zilkova ,Natalia Paulenka-Ivanovova ,Andrej Kovac ,Denisa Palova ,Gabriela Paulikova Rolkova ,Katarina Tomkova ,Natalia Turic Csokova ,Karina Markova ,Michaela Skrabanova ,Kristina Sinska ,Neha Basheer ,Petra Majerova ,Jozef Hanes ,Vojtech Parrak ,Michal Prcina ,Ondrej Cehlar ,Martin Cente ,Juraj Piestansky ,Michal Fresser ,Michal Novak ,Monika Slavikova ,Kristina Borsova ,Viktoria Cabanova ,Bronislava Brejova ,Tomas Vinař ,Jozef Nosek ,Boris Klempa ,Ludek Eyer ,Vaclav Hönig ,Martin Palus ,Daniel Ruzek ,Tereza Vyhlidalova ,Petra Strakova ,Blanka Mrazkova ,Dagmar Zudova ,Gizela Koubkova ,Vendula Novosadova ,Jan Prochazka ,Radislav Sedlacek ,Norbert Zilka ,Eva Kontsekova
